Artikler med krav om offentlig adgang - Xenofon BaraliakosFå flere oplysninger
Ikke tilgængelige nogen steder: 9
Long-term effects of secukinumab on MRI findings in relation to clinical efficacy in subjects with active ankylosing spondylitis: an observational study
X Baraliakos, B Borah, J Braun, D Baeten, D Laurent, J Sieper, P Emery, ...
Annals of the rheumatic diseases 75 (2), 408-412, 2016
Krav: Versus Arthritis, UK, National Institute for Health Research, UK
Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo …
J Rech, K Tascilar, M Hagen, A Kleyer, B Manger, V Schoenau, ...
The Lancet 403 (10429), 850-859, 2024
Krav: European Commission
Physical function and spinal mobility remain stable despite radiographic spinal progression in patients with ankylosing spondylitis treated with TNF-α inhibitors for up to 10 years
D Poddubnyy, A Fedorova, J Listing, H Haibel, X Baraliakos, J Braun, ...
The Journal of Rheumatology 43 (12), 2142-2148, 2016
Krav: Federal Ministry of Education and Research, Germany
Neural network algorithm for detection of erosions and ankylosis on CT of the sacroiliac joints: multicentre development and validation of diagnostic accuracy
T Van Den Berghe, D Babin, M Chen, M Callens, D Brack, H Maes, ...
European radiology 33 (11), 8310-8323, 2023
Krav: Research Foundation (Flanders)
Anti-CD74 IgA antibodies show diagnostic potential for axial spondyloarthritis but are not associated with microscopic gut inflammation
AS De Craemer, T Witte, T Lobaton Ortega, A Hoorens, M De Vos, ...
Rheumatology 62 (2), 984-990, 2023
Krav: German Research Foundation
1995-2025: thirty years of ASAS and its contribution to the understanding of spondyloarthritis
D van der Heijde, V Navarro-Compán, R Landewé, J Sieper, ...
Annals of the Rheumatic Diseases, 2025
Krav: National Institute for Health Research, UK
Editorial Board, Chinese Edition
GBJ Andersson, X Baraliakos, R Ruhrgebiet, F Berenbaum, ...
RHEUMATOLOGY 5 (2), 2019
Krav: US National Institutes of Health
Serum Biomarkers Associated with Changes in ASDAS and MRI Following Treatment of Ankylosing Spondylitis with Golimumab
RD Inman, X Baraliakos, KGA Hermann, J Braun, AA Deodhar, D Heijde, ...
Arthritis and Rheumatology 66, S1137-S1138, 2014
Krav: Government of Spain
Speaker Abstracts (SP01–SP50).
J Ahearn
Rheumatology 51, 2012
Krav: US National Institutes of Health
Tilgængelige et sted: 69
2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis
JV Braun, R van den Berg, X Baraliakos, H Boehm, R Burgos-Vargas, ...
Annals of the rheumatic diseases 70 (6), 896-904, 2011
Krav: Versus Arthritis, UK
Secukinumab, an interleukin-17A inhibitor, in ankylosing spondylitis
D Baeten, J Sieper, J Braun, X Baraliakos, M Dougados, P Emery, ...
New England journal of medicine 373 (26), 2534-2548, 2015
Krav: Versus Arthritis, UK
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update
L Gossec, X Baraliakos, A Kerschbaumer, M de Wit, I McInnes, ...
Annals of the rheumatic diseases 79 (6), 700-712, 2020
Krav: National Institute for Health Research, UK
Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force
JS Smolen, M Schöls, J Braun, M Dougados, O FitzGerald, DD Gladman, ...
Annals of the rheumatic diseases 77 (1), 3-17, 2018
Krav: Versus Arthritis, UK, National Institute for Health Research, UK
Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial
D Baeten, X Baraliakos, J Braun, J Sieper, P Emery, D Van der Heijde, ...
The Lancet 382 (9906), 1705-1713, 2013
Krav: Versus Arthritis, UK
EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice
P Mandl, V Navarro-Compán, L Terslev, P Aegerter, D Van Der Heijde, ...
Annals of the rheumatic diseases 74 (7), 1327-1339, 2015
Krav: UK Medical Research Council
ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update
S Ramiro, E Nikiphorou, A Sepriano, A Ortolan, C Webers, X Baraliakos, ...
Annals of the rheumatic diseases 82 (1), 19-34, 2023
Krav: National Institute for Health Research, UK
Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force
JS Smolen, J Braun, M Dougados, P Emery, O FitzGerald, P Helliwell, ...
Annals of the rheumatic diseases 73 (1), 6-16, 2014
Krav: US National Institutes of Health, Versus Arthritis, UK
Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis
H Appel, G Ruiz‐Heiland, J Listing, J Zwerina, M Herrmann, R Mueller, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2009
Krav: German Research Foundation
High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis
GR Heiland, H Appel, D Poddubnyy, J Zwerina, A Hueber, H Haibel, ...
Annals of the rheumatic diseases 71 (4), 572-574, 2012
Krav: German Research Foundation
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement
P Nash, A Kerschbaumer, T Dörner, M Dougados, RM Fleischmann, ...
Annals of the rheumatic diseases 80 (1), 71-87, 2021
Krav: UK Medical Research Council, National Institute for Health Research, UK
Oplysninger om publikation og økonomisk støtte registreres automatisk af et computerprogram